News|Jiye Bio—One stop CDMSO service platform for biological drug development, manufacture and sales.

+86 18721174739

jiyebio@jeyoupharma.com

About Us

Management Team

Code Of Business Ethics

Quality System

Services

Production services

Cell Bank DS Manufacturing DP Manufacturing

Test Service Items

Service Scope Facility and equipment

Development Services

Cell Line Developemnt Process Development Process Characterization (PC) Process Validation (PV) Analytical Method Development

Registration

Sales Outsourcing Services

CSO

News

Corporate News

Join Us

Talent Philosophy

Employee Growth

Corporate News

2025/02/22

Jiye Bio successfully passed the RAPT customer audit, taking international cooperation to a new level

On December 23, 2024, Jiyu Pharmaceutical and RAPT Therapeutics (referred to as "RAPT") successfully signed an exclusive license agreement...

2024/12

Jiye Bio has reached an important milestone in the construction of new factories and equipment validation, opening a new chapter in pharmaceutical production

On November 8, 2024, the Jiye Bio Joint Plant and supporting equipment and facilities underwent strict testing and evaluation, and successfully passed the verification process...

2024/11

Jiye Bio successfully completed the GMP production of 2000L Phase III clinical biopharmaceuticals in one go ——Laying the foundation for commercial production of innovative drugs for market launch

On December 30, 2024, Jiye Bio successfully achieved GMP production of Phase III clinical samples for the JYB1904 project in a 2000L disposable bioreactor using advanced production technology...